February 9, 2019
New Medicines Verification System: Grünenthal now operates in line with new EU laws that protect patients by preventing counterfeit medicines from being dispensed in pharmacies. With the successful GoLive of one of the most complex programs in the last decade, we have made a decisive contribution to increasing patients’ safety. Read the full story on our global website: Read more
August 10, 2018
Grünenthal has proven its quality for medical devices: Our quality management system has been certified against the important industry standard DIN EN ISO 13485:2016. It confirms that we fulfil the requirement to manufacture medical devices and sell them in Europe. Another major step forward to strengthen our capabilities for Contract Manufacturing Business customers.
July 23, 2018
Grünenthal is setting a new standard in global demand and supply planning capabilities. We have just implemented a new IT solution, SAP Integrated Business Planning, to support the end-to-end IBP process and provide precise and adaptive planning possibilities, automation and seamless data integration. Another major step forward to strengthen our delivery reliability for our Contract Manufacturing Business customers.
June 29, 2018
Today our colleagues in Switzerland celebrate a major milestone: For 25 years they are producing Tramadol in Mitlödi for the global market – this is the world’s largest production unit for Tramadol Hydrochloride. We operate an API-production in top quality: well trained workforce, state of the art facility, precisely controlled processes and efficient Equipment.
Read more (Press release only available in German)
May 23, 2018
TECNANDINA, our Manufacturing Site in Ecuador, was honored from Novartis Ecuador with the annual award “Best Logistic Service Supplier in the Andean Cluster”.
Read more: www.tecnandina.com
Interview in World Pharmaceutical Frontiers